SCHEMBL16147295

SCHEMBL16147295

O=C(c1ccccc1)C(F)(F)c1cnc2ccccc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGAM O43451 1/20 0.54
▸ KDR P35968 1/20 0.50
▸ RAB9A P51151 6/20 0.45
▸ NPC1 O15118 5/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ MAP4K4 O95819 1/20 0.45
▸ CSNK1G2 P78368 1/20 0.45
▸ CLK4 Q9HAZ1 1/20 0.45
▸ MKNK2 Q9HBH9 1/20 0.45
▸ MAP4K5 Q9Y4K4 1/20 0.45
▸ KDM4E B2RXH2 3/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ TRPV1 Q8NER1 1/20 0.44
▸ CFTR P13569 1/20 0.44
▸ CES1 P23141 1/20 0.43
▸ PPARD Q03181 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16148241 0.83 PABPC1 (0.56) RAB9ANPC1SMN1; SMN2ALDH1A1LMNA
SCHEMBL16147513 0.76 PTPN1 (0.53) RAB9ANPC1CES1
SCHEMBL2200591 0.76 CYP1A2 (0.52) MGAMALDH1A1PPARDGLAHPGD
SCHEMBL30831204 0.75 MGAM (0.65) MGAMKDRRAB9ANPC1MAP4K4
SCHEMBL16158204 0.74 PABPC1 (0.46) RAB9ANPC1SMN1; SMN2ALDH1A1TRPV1
SCHEMBL29033265 0.74 CYP1A2 (0.50) MGAMKDM4EALDH1A1TRPV1GLA
Hydrochloric Acid SCHEMBL28009315 0.74 CYP1A2 (0.50) MGAMALDH1A1PPARDGLAHPGD
SCHEMBL15194800 0.73 MGAM (0.47) MGAMKDRRAB9ANPC1SMN1; SMN2
SCHEMBL15194815 0.73 TRPV1 (0.50) MGAMKDRRAB9ANPC1SMN1; SMN2
SCHEMBL16147056 0.73 CES1 (0.64) RAB9ANPC1ALDH1A1LMNACES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9598340-B2 Metal-catalyzed coupling of aryl and vinyl halides with alpha, alpha-difluorocarbonyl compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-03-21 — — US disclosed
US-9598340-B2 Metal-catalyzed coupling of aryl and vinyl halides with alpha, alpha-difluorocarbonyl compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-03-21 — — US disclosed
US-9598340-B2 Metal-catalyzed coupling of aryl and vinyl halides with alpha, alpha-difluorocarbonyl compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-03-21 — — US disclosed
US-20160052854-A1 METAL-CATALYZED COUPLING OF ARYL AND VINYL HALIDES WITH ALPHA, ALPHA-DIFLUOROCARBONYL COMPOUNDS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-02-25 — — US disclosed
WO-2014165861-A1 METAL-CATALYZED COUPLING OF ARYL AND VINYL HALIDES WITH ALPHA, ALPHA-DIFLUOROCARBONYL COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-10-09 — — WO disclosed
WO-2014165861-A1 METAL-CATALYZED COUPLING OF ARYL AND VINYL HALIDES WITH ALPHA, ALPHA-DIFLUOROCARBONYL COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-10-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160052854-A1 METAL-CATALYZED COUPLING OF ARYL AND VINYL HALIDES WITH ALPHA, ALPHA-DIFLUOROCARBONYL COMPOUNDS SOD1, HACL2, VHL MGAM 1246/4885KDR 1848/4885RAB9A 2948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback